Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
1.85 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Verrica Pharmaceuticals Inc. |
Symbool | VRCA |
Munteenheid | USD |
Prijs | 1.85 |
Beurswaarde | 78,936,910 |
Dividendpercentage | 0% |
52-weken bereik | 1.77 - 11.41 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ted White |
Website | https://www.verrica.com |
An error occurred while fetching data.
Over Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)